This Program Announcement replaces PA-02-003.
The purpose of this Program Announcement (PA) is to encourage submission of new
research project grant (R01) and exploratory/developmental grant (R21) applications
to research and develop innovative technologies, methodologies, or instrumentation
for basic or clinical studies of the brain or behavior in human or non-human
animals. Also solicited are applications for support to research, develop, and
significantly enhance existing technologies that are important to understanding the
brain or behavior.
Find Funding Opportunities
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Expiration Date: Tuesday, May 2, 2006 NOFO Number: PA-04-006 Release Date: Wednesday, October 8, 2003 Notice Type: PA
Expiration Date: Wednesday, October 26, 2005 NOFO Number: PAR-03-176 Release Date: Wednesday, September 24, 2003 Notice Type: PAR
This Program Announcement (PA) provides updated guidelines for National
Institutes of Health (NIH) support of scientific meetings. It replaces the
previous guidelines issued in the NIH GUIDE on October 30, 1998,
http://grants.nih.gov/grants/guide/notice-files/not98-151.html and is
effective with the December 15th receipt date for cycle III applications. An
NIH Conference Grant Website has been created to centralize information
regarding grants for scientific meetings and conferences, at
http://grants1.nih.gov/grants/funding/r13/index.htm. This site includes
contact information for the participating NIH Institutes and Centers and
Offices and links to detailed information regarding specific interests and
funding parameters. This site and related links is updated frequently and
interested parties should check periodically for the most current information.
A major revision made in this announcement is the requirement that
applications for conference grant support present a letter from the
appropriate NIH Institute/Center (IC) staff documenting advance permission to
submit an R13 or U13 application. As a streamlining measure, there are now
three annual receipt dates for all applications for support of scientific
meetings, and decisions about awards will normally be made within six months
of submission.
Expiration Date: Thursday, November 2, 2006 NOFO Number: PAR-03-174 Release Date: Wednesday, September 17, 2003 Notice Type: PAR
This PAR replaces PAR-01-119.
The NINDS is committed to identifying effective treatments for neurological
disorders by supporting well-executed clinical trials. Before a definitive
clinical trial can be designed, preliminary clinical studies are often
required. The NINDS announces its interest in supporting studies required to
obtain necessary information to establish clearly the clinical basis for
proceeding to a definitive trial. The purpose of the PRELIMINARY
INVESTIGATIONS LEADING TO OPTIMAL TRIALS IN NEUROLOGY grant (for brevity
referred to as NINDS Preliminary Clinical Trials grant) is to obtain
preliminary data and conduct studies to support the rationale for a subsequent
definitive clinical trial of an intervention to treat or prevent neurological
disease.
Expiration Date: Tuesday, February 1, 2005 NOFO Number: PAS-03-172 Release Date: Tuesday, September 16, 2003 Notice Type: PAS
National Institute of Neurological Disorders and Stroke (NINDS), the National
Institute on Drug Abuse (NIDA), the National Institute of Deafness and Other
Communication Disorders (NIDCD) the National Institute of Alcohol Abuse and
Alcoholism (NIAAA), and the National Institute on Aging (NIA) invite
applications for studies on the cellular and molecular signaling between the
local environment within organisms and stem and progenitor cells that are
either introduced as transplants or are normally resident within host tissues
and organs. The objective of this initiative is to promote a thorough
exploration and characterization of the bi-directional communication between
multipotent cells and the three-dimensional local milieu or niche that they
encounter in vivo under normal and compromised states, such as with aging or
following injury, disease or drug exposure. Of particular interest is the
rigorous characterization of how interactions with localized cues in space
and time regulate stem cell survival, migration, replication and 'plasticity'
in the nervous system and other parts of the body. Projects that address
comparisons between the responses of stem cells within niches in the
developing and mature or aging nervous system in vivo, or in host
microenvironments modified by injury, disease, or by exposure to drugs and
alcohol would also be directly relevant to this Program Announcement with
Set-aside (PAS), as are studies to compare different classes of stem cells or
progeny at progressively more advanced stages of differentiation when placed
in the same sites in vivo.
Expiration Date: Saturday, July 1, 2006 NOFO Number: PAS-03-173 Release Date: Tuesday, September 16, 2003 Notice Type: PAS
The National Institute of Neurological Disorders and Stroke (NINDS), along
with the National Institute of Dental and Craniofacial Research (NIDCR),
invite applications to advance our understanding of the neurobiology of
persistent pain mediated by the trigeminal nerve and to develop effective
therapeutic strategies to alleviate pain associated with disorders of
myofascial, nervous, or skeletal tissues of the head and face, which are
innervated by this nerve. The purpose of this initiative is to foster
research that addresses the mechanisms of pain onset, chronic pain
conditions, and responsiveness to pain therapy through novel basic and
clinical research. Current knowledge of the neurobiology and neurochemistry
of nociception, pain modulation and pain perception needs to be further
developed and correlated with clinical manifestations of craniofacial pain to
improve therapeutic strategies. This Program Announcement with Set-Aside
funds (PAS) contributes to the goals of the NIH Pain Consortium, which is co-
chaired by NINDS, NIDCR, and the National Institute of Nursing Research
(NINR).
Expiration Date: Tuesday, May 2, 2006 NOFO Number: PA-03-169 Release Date: Thursday, September 4, 2003 Notice Type: PA
This Program Announcement (PA) replaces PA-00-105 and PA-00-106.
Under this PA, the National Institute of Mental Health, National Institute on
Aging, National Institute on Alcohol Abuse and Alcoholism, National Cancer
Institute, National Institute of Child Health and Human Development, National
Institute on Drug Abuse, and the National Institute of Neurological Disorders and
Stroke invite research grant applications to expand basic and translational
research on the processes and mechanisms involved in the experience and expression
of emotion.
Expiration Date: Friday, February 20, 2004 NOFO Number: RFA-DK-03-020 Release Date: Thursday, August 28, 2003 Notice Type: RFA
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
National Eye Institute (NEI), National Heart, Lung, and Blood Institute
(NHLBI), National Institute of Allergy and Infectious Diseases (NIAID),
National Institute of Neurological Disorders and Stroke (NINDS), National
Institute of Nursing Research (NINR), National Institute of Child Health and
Human Development (NICHD) invite the small business community to apply
cutting edge technology to research to develop new approaches to prevent,
treat, and cure type 1 diabetes and its complications.
This RFA will utilize the Small Business Innovation Research (SBIR) and Small
Business Technology Transfer (STTR) mechanisms, but will be run in parallel
with other requests for applications (RFAs) of similar scientific scope (DK-
03-015 for Innovative Partners and DK-03-001 for Bench to Bedside) that will
utilize the traditional research project grant (R01), the
exploratory/developmental grant (R21) or the exploratory/developmental grant
phase II (R33) grant mechanisms.
Expiration Date: Saturday, July 1, 2006 NOFO Number: PAS-03-166 Release Date: Thursday, August 28, 2003 Notice Type: PAS
Through this Program Announcement with set-aside funds (PAS), the National
Institute of Neurological Disorders and Stroke invites applications to
support research on reducing disparities in stroke through prevention of
first and recurrent strokes among minority populations. For this PAS,
minority group is defined by race/ethnicity, and includes African American,
Hispanic American, Native American and Alaska Native, and Native Hawaiian and
other Pacific Islanders.
The purpose of the proposed grant program is to foster empirical research
regarding interventions relating to the self-management of risk factors for
first and recurrent stroke among members of minority populations.
Expiration Date: Monday, May 1, 2006 NOFO Number: PAS-03-165 Release Date: Thursday, August 28, 2003 Notice Type: PAS
The goal of this Program Announcement with set-aside funds (PAS) is to invite
applications for studying the neurobiological and cerebrovascular mechanisms
through which the neuroprotective blood-brain and blood-csf barriers function
in the healthy and diseased adult, aged and pediatric brain. Blood-Brain
Barrier (BBB) research embodies the true meaning of a "translational model"
of neuroscience wherein breakthroughs in basic neuroscience are delivered to
the clinic and require an agent delivery strategy and/or the ability to
target specific areas of the brain. This PAS encourages studies focused on
improving our understanding of the neuroprotective CNS barriers and enhancing
the effectiveness of drug and gene delivery strategies for treatment of
neurological diseases. Chief among the challenges to be addressed is the
need to increase our knowledge about the molecular and cellular biology,
cells of origin, gene and protein expression, and the regional differences of
brain microvascular endothelial cells and pericytes and their interactions
with adjacent brain cells.
Expiration Date: Saturday, November 22, 2003 NOFO Number: RFA-NS-04-002 Release Date: Thursday, August 21, 2003 Notice Type: RFA
The NINDS invites applications to validate animal models of
pharmacoresistant epilepsy or intervention in the epileptogenic
processes leading to chronic disease. The goal of this grant program
is to validate proposed models of pharmacoresistant epilepsy and/or
antiepileptogenic models for use in drug discovery. It will establish
baseline data and introduce new methods for evaluating the therapeutic
potential of novel compounds for the treatment of epilepsy.